Pradžia › Šizofrenija › Texas

Šizofrenija klinikiniai tyrimai Texas

34 tyrimai dėl Šizofrenija ieško dalyvių vietose Texas.

Miestai Texas

Oficialus tyrimo tekstas (anglų kalba)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Haracec Clinical Research, El Paso
C-Trilogy Outreach, Longview

Renkami dalyviaiStebimasis tyrimas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07101094

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Community Clinical Research, Inc., Austin
Pillar Clinical Research, LLC, Richardson

Renkami dalyviai1 fazė

Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Local Institution - 0049, Austin
Local Institution - 0194, Dallas
Pillar Clinical Research - Richardson, Richardson

Renkami dalyviai3 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Texas Research Group, Coppell
PsyMed Solutions, Fort Worth
Kaleidoscope Clinical Research, Houston
ir dar 3

Renkami dalyviai3 fazė

Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Neurocrine Clinical Site, Austin
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston

Renkami dalyviai3 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Neurocrine Clinical Site, DeSoto

Renkami dalyviai3 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07227818

Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia

TG Therapeutics Investigational Trial Site, Richardson

Renkami dalyviai2 fazė

Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07680946

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Local Institution - 0149, Dallas
VAST Clinical Research, Garland
Local Institution - 0169, Houston
ir dar 2

Renkami dalyviai3 fazė

Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Adams Clinical Dallas, DeSoto
Re:Cognition Health - Fort Worth, Fort Worth

Renkami dalyviai2 fazė

Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07410507

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Neurocrine Clinical Site, Austin

Renkami dalyviai4 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07105111

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

Pillar Clinical Research, LLC, Richardson

Renkami dalyviai1 fazė

Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-17 · NCT07734493

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

The University of Texas Health Science Center, Houston, Houston

Renkami dalyviai

Amžius nuo 22 iki 65 · Visoms lytims · Atnaujinta 2026-09-16 · NCT05276050

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

Community Clinical Research - Cross Park Drive /ID# 272977, Austin
Pillar Clinical Research - Richardson /ID# 275715, Richardson

Renkami dalyviai2 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07145918

52-week Open Label Safety-Tolerability Study

Adams Clinical, DeSoto
Pillar Clinical Research, Richardson

Renkami dalyviai3 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

VAST Clinical Research, Garland
Local Institution - 0120, Houston
Local Institution - 0066, Spring

Renkami dalyviai3 fazė

Amžius nuo 13 iki 17 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Community Clinical Research, Austin

Renkami dalyviai1 fazė

Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Clinical Site, Austin
Clinical Site, DeSoto
Clinical Site, Richardson

Renkami dalyviai2 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Local Institution - 0016, Austin
Local Institution - 0050, Dallas
Local Institution - 0021, Fort Worth
ir dar 10

Renkami dalyviaiStebimasis tyrimas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT07379827

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

BioXcel Clinical Research Site, DeSoto

Renkami dalyviai1 fazė

Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-08-11 · NCT05025605

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

The University of Texas Health Science Center at Houston, Houston

Renkami dalyviai

Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-08-05 · NCT07060066

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

The University of Texas Health Science Center at Houston, Houston

Renkami dalyviai

Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-08-03 · NCT02916810

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

The University of Texas Health Science Center, Houston, Houston

Renkami dalyviai

Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-07-07 · NCT06961916

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

The University of Texas Health Science Center, Houston, Houston

Renkami dalyviai

Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-07-07 · NCT06345963

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Community Clinical Research, Austin

Renkami dalyviai2 fazė

Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07191483

Deep Brain Stimulation for Psychosis

UT Southwestern Medical Center, Dallas

Renkami dalyviai

Amžius nuo 22 iki 70 · Visoms lytims · Atnaujinta 2026-06-09 · NCT06257056

A Study to Evaluate the Effect of KarXT on Urological Safety

Local Institution - 0001, Austin
InSite Clinical Research, DeSoto

Renkami dalyviai4 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-03 · NCT07221877

CLOZAPINE Response in Biotype-1

UT Southwestern Medical Center, Dallas

Renkami dalyviai4 fazė

Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-05-11 · NCT04580134

Database Registry for Neural Network Biomarkers in Psychosis

University of Texas Southwestern Medical Center, Dallas

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai

Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-04-23 · NCT01409109

Ocrelizumab for Psychosis by Autoimmunity

Houston Methodist Research Institute, Houston

Renkami dalyviai1/2 fazė

Amžius nuo 18 iki 35 · Visoms lytims · Atnaujinta 2026-04-01 · NCT03971487

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

University of Texas Southwestern Medical Center, Dallas

Renkami dalyviaiStebimasis tyrimas

Amžius nuo 18 iki 40 · Visoms lytims · Atnaujinta 2026-03-10 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Neurocrine Clinical Site, Austin
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston

Renkami dalyviai3 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-03-06 · NCT06963034

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

University of Texas at Dallas, Dallas

Renkami dalyviai

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-01-23 · NCT07098169

Randomized Withdrawal Study in Patients With Schizophrenia

Vanda Investigational Site, Austin
Vanda Investigational Site, Houston
Vanda Investigational Site, Irving
ir dar 1

Renkami dalyviai3 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-01-12 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Reviva site, Austin
Reviva site, Richardson

Renkami dalyviai3 fazėLaukiami sveiki savanoriai

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2024-12-19 · NCT05184335

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.